Talk:Bromazolam: Difference between revisions

>Joop
m styling and grammar
>Tracer
m Tracer moved page Bromazolam to Talk:Bromazolam: Moved to talk page
 
(45 intermediate revisions by 12 users not shown)
Line 1: Line 1:
{{decree|type=notice|message=This article is currently in the 'Talk' namespace as an unfinished draft. This section is used to host drafts for unpublished articles and discussions of published ones. If you wish to discuss or suggest improvements to this draft, please do so in the 'Discussion' section at the bottom of the page. This notice will be removed once the draft has been approved for publication by an administrator.}}{{headerpanel|{{Approval}}}}


{{decree|type=notice|message=This article is in the 'Talk' namespace because it is an unfinished draft. This section is used to host drafts for unpublished articles as well as discussions for published ones. If you'd like to use this area to discuss this draft, please do so in the 'Discussion' section at the very bottom of the page. This notice will be removed once this draft has been approved for publication by an administrator.}}{{headerpanel|{{Approval}}}}
<br />


Dosage ranges and duration of action from the most reliable and up to date resource so far?
{{headerpanel|{{DepressantOD|benzodiazepines}}}}
{{Distinguish|Flubromazolam}}
{{SummarySheet}}
{{SubstanceBox/Bromazolam}}


Page 8 of their reports on ROA's and dosage seemed most particularly helpful.  
'''Bromazolam''' (also known as '''Brom''', '''Bromaz''', or '''XLI-268''') is a novel [[psychoactive class::depressant]] belonging to the [[chemical class::benzodiazepine]] class. It exhibits [[anxiolytic]], [[disinhibition]], [[sedative]], [[muscle relaxant]], and [[memory suppression]] effects when administered. Bromazolam is not currently scheduled in many regions globally and is frequently distributed online as a [[research chemical]]. Structurally, it is the bromine-substituted analogue of [[alprazolam]] and has similar pharmacokinetic properties and subjective effects.


Light dosage range is reported to be: (0,5mg-1mg) Common dosage range is reported to be: (1mg-2mg) Strong/heavy dosage range is reported to be:(2mg-4mg)
Like other [[benzodiazepines]], Bromazolam binds to specific sites on the [[GABA<sub>A</sub> receptor]] in the brain, amplifying the inhibitory effects of gamma-aminobutyric acid (GABA).<ref>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303399/</ref> Its availability on the [[clearnet]] and [[darknet]] has increased its use for self-medication and recreational purposes due to its potent effects.


"Onset of effects after oral use is estimated to be 15–45 min, and the duration of action is 5–8 h." - WHO Critical Review findings <ref>[https://cdn.who.int/media/docs/default-source/controlled-substances/45th-ecdd/bromazolam_draft.pdf?sfvrsn=f1bc761e_1https://cdn.who.int/media/docs/default-source/controlled-substances/45th-ecdd/bromazolam_draft.pdf?sfvrsn=f1bc761e_1 WHO Critical Review Report: Bromazolam(2022)]</ref>
It is important to note that the pharmacological properties stated are assumed based on its structure and user reports, as no extensive formal research has been conducted.


The [[benzodiazepine#Discontinuation|sudden discontinuation of benzodiazepines]] after prolonged use can lead to severe withdrawal symptoms, including seizures or death.<ref>A fatal case of benzodiazepine withdrawal. (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pubmed/19465812</ref> Users are strongly advised to [[taper]] their dosage gradually rather than stopping abruptly.<ref>Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain - Appendix B-6: Benzodiazepine Tapering | http://nationalpaincentre.mcmaster.ca/opioid/cgop_b_app_b06.html</ref>


''Bromazolam''' (also known as '''Brom''', '''Bromaz''', or '''XLI-268''') is a [[psychoactive class::depressant]] substance of the [[Chemical class::benzodiazepine]] class - more specifically it is a [[Triazolobenzodiazepine]] (TBZD). Its characteristic effects include [[anxiety suppression]], [[sedation]], [[disinhibition]], and [[muscle relaxation]]. <s>It is currently [[Unscheduled]] in most parts of the world, and hence it is commonly sold as a [[Research chemicals|Research chemical]]</s>. Bromazolam was virtually as unregulated as even the most obscure research chemicals known to man until early 2023 the United States DEA and DOJ working in tandem added Flubramzolam, Etizolam, and several other designer benzodiazepines into Emergency Schedule I. Althought bromazolam itself curiously was not one of the substances added, the fact that flubromazolam and many other very similar drugs are in Emergency Schedule I at the Federal Level. meaning that, as a Schedule I or II illegal narcotic, even bromazolam itself is now illegal federally because Schedule I and II narcotics are covered by the Federal Analogues Act.
==History and Culture==
[[Bromazolam]] (XLI-268) is a [[triazolobenzodiazepine]] (TBZD) first synthesized in 1976 by Hoffman-La Roche. Although initially developed as a potential medication, it was never approved for use and remained unmarketed.<ref>Manchester KR, Lomas EC, Waters L, Dempsey FC, Maskell PD (January 2018). "The emergence of new psychoactive substance (NPS) benzodiazepines: A review". Drug Testing and Analysis. 10 (1): 37–53. doi:10.1002/dta.2211. <nowiki>PMID 28471096</nowiki>. </ref> Bromazolam was first identified in Sweden in 2016 by the EMCDDA and has since been found in nine countries, including Australia, Austria, China, Finland, Germany, India, Sweden, the UK, and the USA.


Like other [[benzodiazepines]], [[Bromazolam]] binds to specific sites on the [[gamma-amino-butyric acid|GABA<sub>A</sub>]] receptor.<ref>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303399/</ref> Since it is not available by prescription and is sold online on [[clearnet]] and [[darknet]] vendors - it is commonly used to self-medicate or for recreational purposes.
In European markets, Bromazolam is often sold as blue Diazepam pills,<ref>https://www.wedinos.org/sample-results</ref> while in the United States, it is more commonly sold as Alprazolam.
 
The [[Benzodiazepine#Discontinuation|sudden discontinuation of benzodiazepines]] can be potentially dangerous or life-threatening for individuals using regularly for extended periods of time, sometimes resulting in seizures or death.<ref>A fatal case of benzodiazepine withdrawal. (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pubmed/19465812</ref> It is highly recommended to [[taper]] one's dose by gradually lowering the amount taken each day for a prolonged period of time instead of stopping abruptly.<ref>Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain - Appendix B-6: Benzodiazepine Tapering | http://nationalpaincentre.mcmaster.ca/opioid/cgop_b_app_b06.html</ref>
 
<!-- Please ensure that any new substance articles are first published in the 'Talk' namespace. For example, a new article on substance XYZ should have the title "Talk: XYZ" instead of "XYZ". Once the submitted article has been reviewed and determined to meet the guidelines and standards, it will be published by a staff member. -->
 
For tips on how to properly format a substance article, please refer to this document: [[Content Style Guide - Substance]]
 
==History and culture==
{{historyStub}}
[[Bromazolam]] (XLI-268) is a [[Triazolobenzodiazepine]] (TBZD) which was first synthesized in 1976,and was developed as a canidate medication, bur was never approved for use, and was never marketed.<ref>Manchester KR, Lomas EC, Waters L, Dempsey FC, Maskell PD (January 2018). "The emergence wiener of new psychoactive substance (NPS) benzodiazepines: A review". Drug Testing and Analysis. 10 (1): 37–53. doi:10.1002/dta.2211. <nowiki>PMID 28471096</nowiki>. </ref> [[Bromazolam]] was first found definitively in Sweden in 2016 by the EMCDDA. Since then, the compound has been detected in products or in biological samples in nine countries: Australia, Austria, China, Finland, Germany, India, and Sweden, the United Kingdom (Wales) and in the USA. [[Bromazolam]] is not under international control.   
 
Bromazolam seems to be commonly sold as blue Diazepam pills <ref>https://www.wedinos.org/sample-results</ref> in the UK.  


==Chemistry==
==Chemistry==
[[File:Alprazolam vs bromazolam.jpg|alt=Comparison between the molecular structures of alprazolam and bromazolam|thumb|323x323px|Chemical Structure Comparison of Alprazolam and Bromazolam. Structures drawn by Kevin G. Shanks (2023).]]
[[File:Alprazolam vs bromazolam.jpg|alt=Comparison between the molecular structures of alprazolam and bromazolam|thumb|323x323px|Chemical structural comparison of Alprazolam and Bromazolam by Kevin G. Shanks (2023).]]
{{chemistry}}
Bromazolam is a chemical analog of [[alprazolam]], where the chlorine atom in alprazolam is replaced by a bromine atom.
Bromazolam is chemically nearly identical to [[Alprazolam|alprazolam]], just with the Chlorine atom substituted with a Bromine atom. Its chemical formula is C<sub>17</sub>H<sub>13</sub>BrN<sub>4</sub>.


==Pharmacology==
==Pharmacology==
{{pharmacology}}
Bromazolam is a triazolobenzodiazepine (TBZD) and was synthesized in 1976, though it was not brought to market.<ref>Manchester KR, Lomas EC, Waters L, Dempsey FC, Maskell PD (January 2018). "The emergence of new psychoactive substance (NPS) benzodiazepines: A review". Drug Testing and Analysis. 10 (1): 37–53. doi:10.1002/dta.2211. <nowiki>PMID 28471096</nowiki>. </ref> It acts as a non-subtype selective agonist at the benzodiazepine (BZD) site of [[GABA<sub>A</sub> receptors]], with a binding affinity of 2.81nM at the α1 subtype, 0.69nM at α2, and 0.62nM at α5.<ref>Benzodiazepine interactions with GABA receptors (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pubmed/6147796</ref> Benzodiazepines enhance the efficiency of GABA neurotransmission, producing sedating and anxiolytic effects<ref>http://www.ncbi.nlm.nih.gov/pubmed/2450203</ref>.
Bromazolam is a triazolobenzodiazepine (TBZD) which was first synthesized in 1976, but was never marketed.[1] It has subsequently been sold as a designer drug, first being definitively identified by the EMCDDA in Sweden in 2016.[2] It is the bromo instead of chloro analogue of alprazolam and has similar sedative and anxiolytic effects to it and other benzodiazepines.[3][4] Bromazolam is a non subtype selective agonist at the benzodiazepine (BZD) site of [[gamma-amino-butyric acid|GABA<sub>A</sub>]] receptors, with a binding affinity of 2.81nM at the α1 subtype, 0.69nM at α2 and 0.62nM at α5.[5] Benzodiazepines produce a variety of effects by binding to the benzodiazepine receptor site and magnifying the efficiency and effects of the neurotransmitter [[GABA|gamma aminobutyric acid (GABA)]] by acting on its [[receptors]].<ref>Benzodiazepine interactions with GABA receptors (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pubmed/6147796</ref> Bromazolam is a positive allosteric modulator of the gamma-aminobutyric acid (GABA) type A receptor. As this site is the most prolific inhibitory receptor set within the brain, its modulation results in the [[sedating]] (or [[anxiety suppression|calming effects]]) of alprazolam on the nervous system. The [[anticonvulsant]] properties of benzodiazepines may be, in part or entirely, due to binding to voltage-dependent sodium channels rather than benzodiazepine receptors.<ref>Benzodiazepines, but not beta carbolines, limit high frequency repetitive firing of action potentials of spinal cord neurons in cell culture. (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pubmed/2450203</ref>  
 
The GABA<sub>A</sub> receptor consists of five subunits out of a possible 19, leading to a wide variety of receptor subtypes with different properties and interactions with benzodiazepines. Triazolobenzodiazepines like Bromazolam may also possess antidepressant properties, potentially due to their chemical similarity to tricyclic antidepressants.<ref>Barbee JG (October 1993). "Memory, benzodiazepines, and anxiety: integration of theoretical and clinical perspectives". ''The Journal of Clinical Psychiatry''. 54 Suppl (Suppl): 86–97, discussion 98–101. <nowiki>PMID 8262893</nowiki>.</ref>


The GABA<sub>A</sub> receptor is made up of 5 subunits out of a possible 19, and GABA<sub>A</sub> receptors made up of different combinations of subunits have different properties, different locations within the brain, and, importantly, different activities with regard to benzodiazepines. Bromazolam and other triazolobenzodiazepines such as triazolam that have a triazole ring fused to their diazepine ring appear to have antidepressant properties.<ref>Barbee JG (October 1993). "Memory, benzodiazepines, and anxiety: integration of theoretical and clinical perspectives". ''The Journal of Clinical Psychiatry''. 54 Suppl (Suppl): 86–97, discussion 98–101. <nowiki>PMID 8262893</nowiki>.</ref> This is perhaps due to the similarities shared with tricyclic antidepressants, as they have two benzene rings fused to a diazepine ring.
==Half Life==
4-8 hours with after effects being reported into the next 12 hours. In some cases people have reported feeling anxiolytic effects well into the 24+ hour mark and withdrawals/rebound anxiety not starting until Day 4/5.


==Subjective effects==
==Subjective Effects==
{{EffectStub}}Bromazolam's headspace is described by some as one of intense sedation, relaxation, anxiety suppression and decreased inhibition. {{Preamble/SubjectiveEffects}}
{{EffectStub}}
Bromazolam's subjective effects include sedation, relaxation, anxiety suppression, and decreased inhibition.


{{Preamble/SubjectiveEffects}}
{{effects/base
{{effects/base
|{{effects/physical|
|{{effects/physical|
Bromazolam's physical effects are mainly those of intense sedation, sleepiness, and muscle relaxation.
Physical effects of Bromazolam are generally marked by intense sedation, sleepiness, and muscle relaxation.  


You may select physical effects to add below [[Subjective effect index#Physical effects|here]].
* '''[[Effect::Sedation]]''' – Can lead to profound drowsiness, including sudden onset of extreme fatigue and "nodding off."
 
* '''[[Effect::Perception of bodily heaviness]]''' – Often accompanies moderate to high doses, leading to a lethargic state where movement is difficult.
*'''[[Effect::Sedation]]'''{{citation needed}} -  Bromazolam is capable of producing strong sedation and can lead to a lethargic state. At higher levels, this causes users to suddenly feel as if they are extremely sleep deprived and need to fight to stay awake. This sleep deprivation increases proportionally to dosage and eventually becomes powerful enough to force the user into a deep state of unconsciousness.
* '''[[Effect::Appetite enhancement]]''' – Reported to stimulate hunger in a manner akin to alcohol.
*'''[[Effect::Perception of bodily heaviness]]''' -  Bromazolam is reported to cause feelings of heaviness in the body. This effect can range from motor impairment and difficulty moving at lower doses to complete lethargy or inability to stand up or move at high doses.
* '''[[Effect::Muscle relaxation]]''' – Effects are more pronounced than with [[alcohol]].
*'''[[Effect::Appetite enhancement]]'''{{citation needed}} - Some users report that bromazolam is capable of enhancing appetite in a manner similar to [[alcohol]] and that it can have a synergistic effect with [[cannabis]].
* '''[[Effect::Motor control loss]]''' – Causes stumbling, clumsiness, and escalated injury risks at higher doses.
*'''[[Effect::Muscle relaxation]]'''{{citation needed}} - Bromazolam is reported to produce moderate muscle relaxation greater than that of [[alcohol]].
* '''[[Effect::Respiratory depression]]''' – Potent at higher doses, it can be fatal when combined with other depressants.
*'''[[Effect::Motor control loss]]'''{{citation needed}} - Bromazolam impairs motor control in a dose-dependent manner similar to [[alcohol]]. Higher doses significantly increase the risk of physical injury via falling over or stumbling into objects. This risk is especially prominent around stairs and slopes.
* '''[[Effect::Dizziness]]''' – Common, especially at high doses.
*'''[[Effect::Respiratory depression]]'''{{citation needed}} - This can be particularly dangerous when combined with other depressants.
* '''[[Effect::Seizure suppression]]''' – May provide anti-convulsant effects like other benzodiazepines.
*'''[[Effect::Dizziness]]'''{{citation needed}} - Dizziness is sometimes present with higher doses, although generally less than the dizzying effects of alcohol (colloquially known as "the spins").
*'''[[Effect::Seizure suppression]]'''{{citation needed}} - Bromazolam may have seizure suppressing properties as a result of its [[GABA|GABA-mediated]] inhibitory effects on the nervous system.


}}
}}
{{effects/visual|
{{effects/visual|
Bromazolam mainly suppresses visual acuity and can cause blurred vision in high doses
Bromazolam can suppress visual acuity, resulting in blurred vision, especially at higher doses.


You may select visual effects to add below [[Subjective effect index#Visual effects|here]].
* '''[[Effect::Visual acuity suppression]]'''
 
* '''[[Effect::Blurred vision]]'''
====Distortions====
* '''[[Effect::Double vision]]
*'''[[Effect::Blurred Vision]]'''
*'''[[Effect::Visual acuity suppression]]''' - Like many [[depressants]], bromazolam is known to cause blurred or otherwise suppressed visual acuity.


}}
}}
|{{effects/cognitive|
|{{effects/cognitive|
Bromazolam's headspace is described by some as one of intense sedation, relaxation, anxiety suppression and decreased inhibition.
Bromazolam primarily impacts cognitive functions such as memory, emotion, and judgment.  
 
You may select from a list of cognitive effects to add below [[Subjective effect index#Cognitive effects|here]].


*'''[[Effect::Analysis suppression]]'''
* '''[[Effect::Analysis suppression]]'''
*'''[[Effect::Anxiety suppression]]'''{{citation needed}}
* '''[[Effect::Anxiety suppression]]'''
*'''[[Effect::Compulsive redosing]]''' - Bromazolam produces [[disinhibition]] which, along with its memory suppressing effects, can easily lead the user to black out and redose continually until their supply runs out or they lose consciousness. This effect can place the user at risk of fatal overdose from respiratory depression if they are consuming it with [[alcohol]] or other [[depressants]].
* '''[[Effect::Compulsive redosing]]''' – Disinhibition combined with memory suppression may lead to frequent and uncontrolled redosing, increasing overdose risk.
*'''[[Effect::Confusion]]''' - Bromazolam can cause confusion at heavy doses. This effect is a result of the drug suppressing basic cognitive functions such as comprehension, memory, and reasoning skills.
* '''[[Effect::Confusion]]'''
*'''[[Effect::Delusions|Delusions of sobriety]]''' - This is the false belief that one is perfectly sober despite obvious evidence to the contrary such as severe cognitive impairment and an inability to fully communicate with others. It most commonly occurs at heavy dosages.
* '''[[Effect::Delusions|Delusions of sobriety]]'''
*'''[[Effect::Disinhibition]]
* '''[[Effect::Disinhibition]]'''
*'''[[Effect::Dream suppression]]'''{{citation needed}} - Benzodiazepines like bromazolam generally inhibit REM sleep and suppress the experience of dreaming. Sleep on benzodiazepines is generally reported to be deep and refreshing, although it should be noted that the actual sleep quality is lower which is why the use of benzodiazepines as long-term sleep aids is not advised.
* '''[[Effect::Dream suppression]]'''
*'''[[Effect::Emotion suppression]]''' - Although bromazolam primarily suppresses anxiety, it also dulls other emotions in a manner which is distinct but less intensive than that of [[antipsychotics]].
* '''[[Effect::Emotion suppression]]'''
*'''[[Effect::Euphoria]]''' - A distinct portion of users report feeling a marked sense of emotional well-being and comfort while under the influence of this substance. Because this does not occur regularly or consistently for most users, it is speculated that this effect only manifests among those who have unusually high baseline levels of anxiety.
* '''[[Effect::Euphoria]]'''
*'''[[Effect::Language suppression]]''' - Bromazolam is capable of causing slurred speech and difficulty communicating words in a clear fashion.
* '''[[Effect::Language suppression]]'''
*'''[[Effect::Memory suppression]]'''{{citation needed}} - Bromazolam primarily suppresses short-term memory, resulting in forgetfulness, and/or disorganized behaviors.
* '''[[Effect::Memory suppression]]'''
**'''[[Effect::Amnesia]]''' - Higher doses of bromazolam can easily lead to complete short-term amnesia (black out) similar to that of high doses of alcohol. User reports claim Bromazalam more easily induces blackouts than other similar compounds at similar doses
* ** '''[[Effect::Amnesia]]''' – Particularly at high doses, Bromazolam can cause blackouts, making users forget periods while under its influence.
*'''[[Effect::Motivation suppression]]''' - Due to bromazolam's heavy sedation and lethargy, doing any type of activity that requires moving, or high amounts of effort may be difficult to do, especially at higher doses.
* '''[[Effect::Motivation suppression]]'''
*'''[[Effect::Sleepiness]]'''
* '''[[Effect::Sleepiness]]'''
*'''[[Effect::Thought deceleration]]'''
* '''[[Effect::Thought deceleration]]'''


}}
}}
{{effects/aftereffects|
{{effects/aftereffects|
* '''Rebound [[Effect::Anxiety]]'''
* '''[[Effect::Dream potentiation]]''' <ref>Goyal, Sarita. "Drugs and Dreams." Indian Journal of Clinical Practice (n.d.): n. pag. Web.  | http://medind.nic.in/iaa/t13/i3/iaat13i3p624.pdf</ref>
* '''Residual [[Effect::Sleepiness]]'''
* '''[[Effect::Thought deceleration]]''' 
* '''[[Effect::Thought disorganization]]'''
* '''[[Effect::Irritability]]'''


*'''Rebound [[Effect::anxiety]]''' - Rebound anxiety is a commonly observed effect with [[anxiety suppression|anxiety relieving]] substances like [[benzodiazepines]]. It typically corresponds to the total duration spent under the substance's influence along with the total amount consumed in a given period, an effect which can easily lend itself to cycles of dependence and addiction.
}}}}
*'''[[Effect::Dream potentiation]]'''<ref>Goyal, Sarita. "Drugs and Dreams." Indian Journal of Clinical Practice (n.d.): n. pag. Web.  | http://medind.nic.in/iaa/t13/i3/iaat13i3p624.pdf</ref>
*'''Residual [[Effect::sleepiness]]''' - While benzodiazepines can be used as an effective [[hypnotic|sleep-inducing]] aid, their effects may persist into the morning afterward, which may lead users to feeling "groggy" or "dull" for up to a few hours.
*'''[[Effect::Thought deceleration]]'''
*'''[[Effect::Thought disorganization]]'''
*'''[[Effect::Irritability]]'''


===Experience Reports===
There are currently {{#ask:[[Category:Bromazolam]][[Category:Experience]] | format=count}} experience reports available in our [[experience index]].


}}}}
Additional experience reports for Bromazolam can be found here:
===Experience reports===
There are currently {{#ask:[[Category:SUBSTANCE]][[Category:Experience]] | format=count}} experience reports which describe the effects of this substance in our [[experience index]].
{{#ask: [[Category:SUBSTANCE]][[Category:Experience]]|format=ul|Columns=1}}
Additional experience reports can be found here:


*[https://www.erowid.org/experiences/subs/exp_Bromazolam_Retrospective_I_Summary.shtml Erowid Experience Vaults: Bromazolam]
*[https://www.erowid.org/experiences/subs/exp_Bromazolam_Retrospective_I_Summary.shtml Erowid Experience Vaults: Bromazolam]


==Toxicity and harm potential==
==Toxicity and Harm Potential==
{{toxicity|Dosage=0.5-1mg - Light
{{toxicity|Dosage=0.5-1 mg - Light<br> 1 mg-3 mg - Moderate<br> 3 mg-5 mg+ - Strong}}
1mg-3mg - Moderate
Research on the toxicity of Bromazolam has not been done, however there large amounts of overdoses have been reported in relation to Bromazolam. It is strongly recommended to employ [[responsible use|harm reduction practices]] while using this or any substance.
3mg-5mg+ - Strong}}
It is strongly recommended that one use [[responsible use|harm reduction practices]] when using this substance.
===Lethal dosage===
The only thing I can find in the way of dosage is an individual report from a user who claimed<ref>https://erowid.org/experiences/exp.php?ID=115168</ref>:
 
Recreational: 4-6 mg
 
Intoxicated: 6+ mg


Hypnotic: n/a (never reached this point)
===Tolerance and Addiction Potential===
Long-term use of Bromazolam can lead to tolerance, physical dependence, and withdrawal symptoms associated with benzodiazepines, including the potential for life-threatening withdrawal seizures. Notably, tolerance to Bromazolam builds more quickly than with other benzodiazepines, increasing the risk of dependence.


Duration would be typically be 6-8 hours, with amnesic effects continuing into the next 1-2 days.
===Dangerous Interactions===
Like other benzodiazepines, Bromazolam should not be mixed with alcohol or other central nervous system depressants due to the high risk of fatal overdose caused by respiratory depression.


<br />
===Tolerance and addiction potential===
<br />
===Dangerous interactions===
{{DangerousInteractions}}
{{DangerousInteractions}}
{{DangerousInteractions/Intro}}
{{DangerousInteractions/Intro}}


==Legal status==
{{DangerousInteractions/Depressants}}
{{LegalStub}}Bromazolam is unscheduled in most of the world.


Bromazolam is a class c scheduled substance in the UK.<ref>https://publichealthscotland.scot/publications/rapid-action-drug-alerts-and-response-radar-alerts/radar-bromazolam-alert-2023/legal-status/#:~:text=In%20the%20UK%2C%20many%20benzodiazepines,be%20due%20to%20international%20control.</ref>
==Legal Status==
[[Bromazolam]] is currently unscheduled in many countries, though some states and nations have specific controls:


In America, Bromazolam is unscheduled federally, but is schedule 1 at the state level in places such as virginia.  
- **United Kingdom:** Classified as a Class C controlled substance.<ref>https://publichealthscotland.scot/publications/rapid-action-drug-alerts-and-response-radar-alerts/radar-bromazolam-alert-2023/legal-status/#:~:text=In%20the%20UK%2C%20many%20benzodiazepines,be%20due%20to%20international%20control.</ref>
- **United States:** Federally unscheduled, though state-level regulations like in Virginia have placed Bromazolam into Schedule I.<ref>https://web.archive.org/web/20230323012949/https://law.lis.virginia.gov/vacode/title54.1/chapter34/section54.1-3446/</ref>.
- **Canada:** Classified as a Schedule IV controlled substance.
- **Germany:** Subject to national control legislation.


==See also==
==See Also==


*[[Responsible use]]
*[[Responsible use]]


==External links==
==External Links==
(List along order below)


*[https://en.wikipedia.org/wiki/SUBSTANCE SUBSTANCE (Wikipedia)]
*[https://en.wikipedia.org/wiki/Bromazolam Bromazolam (Wikipedia)]
*SUBSTANCE (Erowid Vault)
*[https://www.erowid.org/experiences/subs/exp_Bromazolam.shtml Bromazolam (Erowid Vault)]
*SUBSTANCE ([''PiHKAL'' or ''TiHKAL''] / Isomer Design)
*[https://isomerdesign.com/PiHKAL/explore.php?domain=pk&id=3065 Bromazolam (Isomer Design)]
*[https://cdn.who.int/media/docs/default-source/46th-ecdd/bromazolam_46th-ecdd-critical-review_public-version.pdf?sfvrsn=4f1bccfa_1 WHO Critical Report October 2023]


==Literature==
==Literature==


*APA formatted reference
*APA formatted references


Please see the [[citation formatting guide]] if you need assistance properly formatting citations.
Refer to the [[citation formatting guide]] for help in properly formatting citations.


==References==
==References==
Return to "Bromazolam" page.